2023 Department of Medicine Grand Rounds | Mucus-degrading Microbiome and Toxicities of Hematopoietic Cell Transplantation
Hematopoietic cell transplantation (HCT) is used to treat hematologic malignancies. The microbiome has found to be associated with differences in outcomes of HCT. It is important to understand how the microbiome can modulate outcomes after hematopoietic cell transplantation.
Studies regarding the microbiome and hematopoietic cell transplantation outcomes have been performed recently and may not be widely known among cancer providers. It is imperative that clinicians stay abreast of the advances in this area. This lecture will discuss published and unpublished data, and will help educate providers regarding the microbiome in HCT.
- Analyze mucus degrading intestinal bacterial subsets.
- Examine which clinical hematopoietic cell transplantation (HCT) outcomes are associated with mucus degrading intestinal bacteria.
- Identify risk factors leading to increased activity from mucus-degrading intestinal bacteria.
- Discuss strategies to potentially protect intestinal mucosa.
Virtual Meeting- Zoom
Robert Jenq, MD Associate Professor and Deputy Chair, Department of Genomic Medicine; Director, Microbiome Core Facility; University of Texas MD Anderson Cancer Center
Presenter: Dr. Jenq has indicated that he is a Consultant for Kaleido Biosciences, LISCure Biosciences, Maat Pharma, Prolacta Biosciences, and Seres Therapeutics.
Planner: James Lin, MD has indicated no relevant financial relationships.
The educational content has been peer-reviewed, an attestation on file and no conflicts were noted.
CME Committee/Reviewer Nothing to Disclose: Daneng Li, MD
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2023 Department of Medicine Grand Rounds | Mucus-degrading Microbiome and Toxicities of Hematopoietic Cell Transplantation for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance